Scientific Summits conference — Mechelen, 18 & 19 June 2021

We have the honour and the pleasure to invite you to our first Scientific Summits conference of 2021, which will take place on Friday 18 & Saturday 19 June in the beautiful Van Der Valk Hotel in Mechelen.

Register your seat today, it will undoubtedly be an event not to be missed!

LIVE PRESENCE & ONLINE STREAM

We will welcome as many guests as possible, live in Mechelen, obviously taking into account the corona measures applicable at that moment.

To give everyone the opportunity to attend the conference, all sessions will also be recorded and broadcasted online with the help of a high profile technical partner, enabling speakers, attendees & experts to discuss in a virtual ZOOM conference room.

TOP SPEAKERS, TOP CONTENT

As usual, we are proud to once again offer a varied program, with top key opinion leaders & international experts, offering insights into important novelties in the field of urothelial, prostate and kidney cancer.

Friday 18 & Saturday 19 June 2021

Van Der Valk Hotel in Mechelen, Belgium

Hybrid meeting

Scientific program

Friday 18 June 2021
12:00
Lunch (COVID proof)
13:15 – 13:20
Start of the event — WELCOME & INTRODUCTION
13:20 – 13:50
PART 1 — Bring your own case: UC and RCC

Juniors can present too!

13:50 – 15:35
PART 2 — Urothelial cancer

Chairs
Prof. Dr. Karel Decaestecker – UZ Gent, Belgium
Prof. Dr. Brieuc Sautois – CHU Liège, Belgium
Prof. Dr. Gert De Meerleer – UZ Leuven, Belgium

  • 13:50 – 14:15
    Evolving landscape in the treatment of BCG refractory and BCG naive NMIBC
    Prof. Dr. Evanguelos Xylinas – Urology – Hôpitaux de Paris, France
  • 14:15 – 14:40
    Evolving landscape in the neoadjuvant and adjuvant treatment of MIBC
    Prof. Dr. Tom Powles – Genito-urinary oncology – Barts Cancer Centre – London, UK
  • 14:40 – 15:10
    New kids on the block in metastatic urothelial cancer
    Prof. Dr. Brieuc Sautois – Medical Oncology – CHU Liège, Belgium
  • 15:10- 15:35
    Hypofractionated radiotherapy for bladder cancer: a game changer?
    Prof. Dr. Robert Huddart – Royal Marsden Hospital – London, UK
15:35 – 16:05
Coffee break
16:05 – 17:45
Part 3 — Renal cell cancer

Chairs
Prof. Dr. Steven Joniau – UZ Leuven, Belgium
Prof. Dr. Brieuc Sautois – CHU Liège, Belgium
Prof. Dr. Thierry Quackels – Hôpital Erasme Brussels, Belgium

  • 16:05 – 16:30
    Metastasis-directed therapy in oligorecurrent RCC patients: worth the effort? 
    Prof. Dr. Maarten Albersen – Urology – Leuven University Hospitals, Belgium
  • 16:30 – 16:55
    My personal take on managing advanced kidney cancer – patient selection and treatment decision tree 
    Prof. Dr. Axel Bex – Urology – Antoni van Leeuwenhoek – Amsterdam, The Netherlands
  • 16:55 – 17:45
    Robotic partial nephrectomy
    Prof. Dr. Karel Decaestecker – Urology – UZ Gent, Belgium
17:45 – 17:50
Review & conclusions
17:50 – 18:50
Commercial break
20:00
Congress diner (COVID proof)
Saturday 19 June 2021
09:00 – 09:30
Part 1 — Bring your own case: Prostate cancer

Juniors can present too!

09:30 – 11:20
Part 2 — Prostate  cancer

Chairs
Prof. Dr. Steven Joniau – UZ Leuven, Belgium
Dr. François-Xavier Otte – Jules Bordet Instituut Brussels, Belgium
Dr. Gregoire Assenmacher – Europe Hospitals Brussels, Belgium

  • 09:30 – 09:55
    The role of extended LND in PCa
    Prof. Dr. Alberto Briganti – Urology – Università Vita-Salute San Raffaele – Milan, Italy
  • 09:55 – 10:25
    Do’s and don’ts in postoperative radiotherapy: timing, hormones and dose
    Prof. Dr. Alberto Bossi – Radiation Oncology – IGR – Paris, France
  • 10:25 – 10:55
    Metastatic hormone-sensitive prostate cancer: all hands up for systemic treatment: targeting the primary tumor is obsolete
    Prof. Dr. Karim Fizazi – Medical Oncology – IGR – Paris, France
  • 10:55 – 11:20
    Metastatic hormone-sensitive prostate cancer: targeting the primary tumor is mandatory
    Prof. Dr. Nicolaas Lumen – Urology – UZ Gent, Belgium
11:20 – 11:50
Commercial break
11:50 – 12:35
Part 3 — Mini symposium
by FERRING

Update on Androgen Deprivation Therapy (ADT)

  • CV Disease and ADT where do we stand?
    Prof. Dr. Bertrand Tombal – Cliniques universitaires Saint-Luc, Belgium
  • Role of adjuvant ADT to radiation therapy in oligometastatic recurrent PCa? Treatment duration?
    Dr. Piet Dirix – GZA Antwerpen, Belgium
  • Is there a role of Neo-adjuvant ADT before prostatectomy?
    Prof. Dr. Steven Joniau – UZ Leuven, Belgium
12:35 – 14:05
Part 4 — Ethics & Economy

Chairs
Dr. Lieven Goeman – AZ Delta Roeselaere, Belgium
Dr. Marc Claessens – AZ Klina Brasschaat, Belgium

  • 12:35 – 14:05
    Value based health care in uro oncology: fancy words or future reality
    Dr. Filip Ameye – Urology – Maria Middelares Hospital Gent, Belgium
14:05 – 14:10
Review & conclusions
14:10
Lunch (COVID proof)